Other
Manganese oxides other than manganese dioxide
HSN 2820 90 00 (Other manganese oxides) is subject to Central Board of Indirect Taxes and Customs (CBIC) mandatory declaration overlays, including Chapter 28 chemical-qualifier requirements under CBIC Circular 23/2023-Cus dated 30-09-2023. Where the imported product constitutes a drug or pharmaceutical intermediate, five additional CBIC-mandated documents must be uploaded in e-Sanchit before customs out-of-charge.
- Chapter 28 qualifiers from CBIC
- Certificate of Analysis from supplier
- Registration certificate from CDSCO
- 1Include all mandatory additional qualifiers in the import declaration for Chapter 28 commodities as stipulated in paragraphs 4.1 and 4.2 of CBIC Circular 23/2023-Cus, with effect from 15 October 2023. Failure to include the prescribed qualifiers will result in the bill of entry being flagged for manual examination and potential detention.CBIC Circular 23/2023-Cus dated 30-09-2023, paras 4.1 and 4.2
- 2Where the consignment is classified as a drug or pharmaceutical intermediate, upload all five mandatory documents in e-Sanchit before filing the bill of entry: Certificate of Analysis — Drug (0010dc), Batch Release Certificate (0030dc), Label of Consignment (0110dc), Registration Certificate — Drugs (101dc1), and Import Licence for Drugs (9111dc).CBIC Circular 23/2023-Cus dated 30-09-2023 · e-Sanchit document codes 0010dc, 0030dc, 0110dc, 101dc1, 9111dc
The most common error on this tariff line is assuming that manganese oxides are purely industrial inorganic chemicals and overlooking the drug-document overlay. Where the imported product is a pharmaceutical-grade or API-grade manganese compound destined for drug manufacture, the absence of even one of the five e-Sanchit drug documents — particularly the Import Licence for Drugs (9111dc) or the Registration Certificate (101dc1) — will prevent customs out-of-charge and expose the consignment to detention and ground rent.